v3.26.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Apr. 30, 2026
Apr. 30, 2025
Current assets:    
Cash $ 4,872 $ 9,785
Accounts receivable, net 13,178 11,204
Prepaid expenses and other current assets 1,169 1,369
Total current assets 19,219 22,358
Operating lease right-of-use assets, net 3,697 5,080
Property and equipment, net 3,526 4,375
Other long term assets 212 196
Goodwill 335 335
Total assets 26,989 32,344
Current liabilities:    
Accounts payable 6,903 4,248
Accrued liabilities 2,592 2,556
Current portion of operating lease liabilities 1,520 1,471
Other current liabilities 79 135
Deferred revenue 8,828 15,443
Total current liabilities 19,922 23,853
Non-current portion operating lease liabilities 2,992 4,634
Other non-current liabilities 7 85
Total liabilities 22,921 28,572
Stockholders' equity:    
Common stock, $.001 par value; 200,000,000 shares authorized; 14,007,159 and 13,897,503 shares issued; and 13,886,826 and 13,777,170 shares outstanding at April 30, 2026 and 2025, respectively 14 14
Treasury Stock, at cost (708) (708)
Additional paid-in capital 85,700 84,358
Accumulated deficit (81,067) (79,892)
Total stockholders’ equity attributable to Champions Oncology, Inc. 3,939 3,772
Noncontrolling interest 129 0
Total stockholders' equity 4,068 3,772
Total liabilities and stockholders' equity $ 26,989 $ 32,344